Abstract
Background Reliable data on the burden of opportunistic infections (OIs) after antiretroviral therapy (ART) initiation is critical for planning health services and reducing OI-related morbidity and mortality. Nevertheless, there has been no nationally representative information on the prevalence of OIs in our country. Therefore, we have undertaken this comprehensive systematic review and meta-analysis to estimate the pooled prevalence, and identify potential risk factors associated with the development of OIs in HIV (Human Immunodeficiency Virus)-infected adults receiving ART in Ethiopia.
Methods Articles were searched in international electronic databases. A standardized Microsoft Excel spreadsheet and STATA software version 16 were used for data extraction and analysis, respectively. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) checklist was used to write this report. The random-effect meta-analysis model was used to estimate pooled effect. Statistical heterogeneity of the meta-analysis was checked. Subgroup and the sensitivity analyses were also performed. Publication bias was examined funnel plots and the nonparametric rank correlation test of Begg and the regression-based test of Egger. Association was expressed through a pooled odds ratio (OR) with a 95% Confidence Interval (CI)
Results A total of 12 studies with 6163 study participants were included. The overall estimated pooled prevalence of OIs was 43.97% (95 % CI (38.59, 49.34). Poor level of adherence to ART (OR, 5.90 (95% CI (3.05, 11.40), under nutrition (OR, 3.70 (95% CI (2.01, 6.80), CD4 T lymphocytes count <200 cells /µL (OR, 3.23 95% CI (2.06, 5.07), and advanced World Health Organization (WHO) HIV clinical stages (OR, 4.84 (95% CI (1.83, 12.82) were predictors of OIs.
Conclusion The pooled prevalence OIs among adults taking ART is high. Poor adherence to ART, under nutrition, CD4 T lymphocyte counts <200 cells /µL, and presentation with advanced WHO HIV clinical stages were factors associated with the development of OIs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files
Abbreviations/Acronyms
- AIDS
- Acquired Immunodeficiency Syndrome
- ART
- Antiretroviral Therapy
- CI
- Confidence Interval
- HIV
- Human Immunodeficiency Virus
- JBI
- Johanna Briggs Institute
- LMICs
- Low-and Middle Income countries
- OIs
- Opportunistic Infections
- OR
- Odds ratio
- PLHIV
- People Living with HIV
- SNNPRs
- Southern Nations Nationalities Peoples’ Regional State
- WHO
- World Health Organization
